Pevet Antibacterial Ear Drops for Dogs & Cats – Florfenicol & Metronidazole for Otitis Treatment, 20ml

Product Overview

Pevet Ear® is an advanced, dual-action veterinary otic solution formulated for the effective treatment of bacterial otitis in dogs and cats. Combining two potent active ingredients—Florfenicol and Metronidazole—this preparation provides broad-spectrum antibacterial coverage against both aerobic and anaerobic pathogens. Specifically developed for clinical settings and veterinarian-directed treatment, EarClea ensures rapid therapeutic penetration and sustained release mechanisms, delivering comprehensive therapy deep within the ear canal to eradicate infections and mitigate inflammation.

Indications for Use

Pevet EarClea is indicated for the treatment of:

• Bacterial Otitis Externa and Media: Comprehensive coverage against primary pathogens like Staphylococcus spp., Pseudomonas aeruginosa, and mixed aerobic/anaerobic infections.
• Secondary Bacterial Infections: Addressing complications arising from dermatitis, atopic reactions, foreign bodies, humid conditions, or fungal infections.
• Chronic or Recurrent Otitis: Orchestrating therapy for persistent inflammatory conditions or mixed pathogen cases.
• Symptomatic Relief: Effectively alleviating clinical signs including pruritus, erythema, edema, malodorous exudate, pain, head tilting/shaking, and pathological cerumen overproduction.

Supported by Veterinary Drug Registration No. 180766015, this product adheres to stringent regulatory standards for safety and therapeutic confirmation.

Mechanism of Action:

• Florfenicol: A synthetic fluorinated analogue of thiamphenicol, it acts via binding to the 50S ribosomal subunit, inhibiting bacterial protein synthesis. Exhibits notable activity against Gram-positive and Gram-negative bacteria, including drug-resistant strains commonly implicated in otic pathologies.
• Metronidazole: A nitroimidazole-class antiprotozoal and antibacterial agent targeting anaerobic organisms and specific protozoa by disrupting DNA helical structure. It catalytically mediates cytotoxic intermediates following reduction by metabolic enzymes unique to anaerobes.

This synergistic compound ensures broad-spectrum coverage not only against primary isolates but also reduces bacterial rebound risks by simultaneouslyes and anaerobes.

Key Advantages

1. Dual-Action Therapy: By unifying dual antibiotics with distinct pharmacodynamic targets, EarClea prevents overwhelming bacterial evasion strategies encountered in monotherapies.
2. Rapid Bioavailability: Formulation assures profound and rapid otic tissue penetration for quick anti-inflammatory actions and relief onset.
3. Clinically Validated Efficacy: Documented high success rates in resolving clinical otitis syndromes without relapse under compliance.
4. Optimal Pharmacy: Delivered in precise-dose tapered bottles with tactile droppers to facilitate seamless administration even in agitated animals.

Dosage and Administration

Standard Therapeutic Regimen:

• Apply 3–4 drops directly into the afflicted ear canal.
• Repeat twice daily for 5–7 consecutive days.
• Ensure post-instillation auricular massage at the base (~15 seconds) aids optimal occlusion and medication dispersal. Note: Prolonged protocols adapted to severity/duration may be veterinarian-directed.

Packaging & Specifications

• Volume: 20ml sterile vial
• Cartoning Details:
• 20ml/bottle (shelf-ready design)
• Units per Case: 96 bottles/carton
• Carton Dimensions: 31 × 30.5 × 19 cm
• Storage: Between 15-30°C (dry ambient; avoid direct light or humidity)

Safety & Compliance

• Licensed Use Only: Restricted to professional veterinary practices.
• Client Advisory: Keep secure from children. Post-administration, prevent self-trauma (e.g., neck collar disc.)
• Environment: Avoid effluent disposition. Follow regional disposal protocols for veterinary biologicals.

Why Esteem EarClea?

→ Vetted by Efficacy: Trusted data in clinical scenarios affirms dependable eradication of otitis pathogens.
→ High-Compliance: Mechanical droppers mitigate spillage & overdosing concerns.
→ Economics: Batch-packaged for institutional economics; price-efficiency without therapeutic compromise.

Discover the therapeutic edge in bacterial otitis management. For veterinary wholesalers or clinic-franchised queries, conduct a formal inquiry with us for bulk propositions and regulatory certifications.